Publicaciones en las que colabora con XOSE R. GARCIA BUSTELO (31)

2024

  1. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

2022

  1. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  2. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

    Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553

  3. The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function

    Oncogene, Vol. 41, Núm. 24, pp. 3341-3354

2021

  1. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis

    EMBO Journal, Vol. 40, Núm. 22

  2. Distinct roles of vav family members in adaptive and innate immune models of arthritis

    Biomedicines, Vol. 9, Núm. 6

  3. Efficient fractionation and analysis of ribosome assembly intermediates in human cells

    RNA Biology, Vol. 18, Núm. S1, pp. 182-197

  4. New functions of vav family proteins in cardiovascular biology, skeletal muscle, and the nervous system

    Biology, Vol. 10, Núm. 9

2020

  1. Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity

    Frontiers in Cell and Developmental Biology, Vol. 8

  2. Identification of distinct maturation steps involved in human 40S ribosomal subunit biosynthesis

    Nature Communications, Vol. 11, Núm. 1

  3. Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera

    Small GTPases, Vol. 11, Núm. 4, pp. 233-239

  4. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma

    Nature Communications, Vol. 11, Núm. 1

  5. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor

    Oncogene, Vol. 39, Núm. 28, pp. 5098-5111

2019

  1. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms

    Oncogene, Vol. 38, Núm. 2, pp. 209-227

2018

  1. An unexpected tumor suppressor role for VAV1a

    Molecular and Cellular Oncology, Vol. 5, Núm. 3

  2. Ribosome biogenesis and cancer: basic and translational challenges

    Current Opinion in Genetics and Development, Vol. 48, pp. 22-29

2017

  1. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

    Cancer Cell, Vol. 32, Núm. 5, pp. 608-623.e9

  2. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 4, pp. 764-769

  3. Focal accumulation of preribosomes outside the nucleolus during metaphase-anaphase in budding yeast

    RNA, Vol. 23, Núm. 9, pp. 1432-1443